Back to Search Start Over

OC-0270: QoL and toxicity of HDR prostate brachytherapy as monotherapy 19Gy single fraction:phase II trial.

Authors :
Gomez-Iturriaga, A.
Casquero, F.
Minguez, P.
Espinosa, J.
Bueso, A.
Cacicedo, J.
Fernandez, L.
Pedraza, S.
Garcia Escovedo, J.
Bilbao, P.
Source :
Radiotherapy & Oncology. May2017 Supplement 1, Vol. 123, pS139-S140. 1p.
Publication Year :
2017

Details

Language :
English
ISSN :
01678140
Volume :
123
Database :
Academic Search Index
Journal :
Radiotherapy & Oncology
Publication Type :
Academic Journal
Accession number :
124044038
Full Text :
https://doi.org/10.1016/S0167-8140(17)30713-2